[HTML][HTML] The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review
Several risk factors for Coronavirus-2019 (COVID-19) disease have been highlighted in
clinical evidence. Among the various risk factors are advanced age, metabolic illness such …
clinical evidence. Among the various risk factors are advanced age, metabolic illness such …
Anxio-depressive disorders in a pandemic context: A comparative analysis: year 2019 versus 2020
AR Droahnă, LA Moroianu, VA Pietroșel… - Journal of Mind and …, 2023 - scholar.valpo.edu
The outbreak of SARS-CoV-2 pandemic has resulted in increased rates of anxiety and
depression worldwide. Objective. To comparatively evaluate factors associated with the …
depression worldwide. Objective. To comparatively evaluate factors associated with the …
[HTML][HTML] The psychological challenges of respiratory disease
E Volpato, P Banfi, M Verkleij - Frontiers in psychology, 2023 - frontiersin.org
Over the last few decades, there has been a growing body of literature on the influence that
psychological factors can have on chronic respiratory diseases and how these, in turn, might …
psychological factors can have on chronic respiratory diseases and how these, in turn, might …
Pilot of a therapist‐guided digital mental health intervention (eHealth CF‐CBT) for adults with cystic fibrosis
M Verkleij, AM Georgiopoulos… - Pediatric …, 2023 - Wiley Online Library
Abstract Background eHealth CF‐CBT is the first digital mental health intervention for
depression/anxiety in adults with cystic fibrosis (awCF); an 8‐session therapist‐guided …
depression/anxiety in adults with cystic fibrosis (awCF); an 8‐session therapist‐guided …
Mental health, sleep, and respiratory health after initiating elexacaftor/tezacaftor/ivacaftor treatment in children with cystic fibrosis
H Pham, M Vandeleur, RM Mainzer… - Pediatric … - Wiley Online Library
Introduction Cystic fibrosis transmembrane conductance regulator (CFTR) modulator
elexacaftor/tezacaftor/ivacaftor (ETI) significantly improves lung function but its effect on …
elexacaftor/tezacaftor/ivacaftor (ETI) significantly improves lung function but its effect on …
[PDF][PDF] The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature
Several risk factors for Coronavirus-2019 (COVID-19) disease have been highlighted in
clinical evidence. Among the various risk factors are advanced age, metabolic illness such …
clinical evidence. Among the various risk factors are advanced age, metabolic illness such …